Jump to content

Antisense RNA: Difference between revisions

From Wikipedia, the free encyclopedia
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
No edit summary
No edit summary
Line 1: Line 1:
'''Antisense RNA''' (asRNA) is a single-stranded [[RNA]] that is [[complementarity (molecular biology)|complementary]] to a [[messenger RNA]] (mRNA) strand [[transcription (genetics)|transcribed]] within a [[cell (biology)|cell]]. Some authors have used the term [[micRNA]] (mRNA-interfering complementary RNA) to refer to these RNAs but it is not widely used.<ref name="pmid6201848">{{Cite pmid|6201848}}</ref>
'''Antisense RNA''' (asRNA) is a single-stranded [[RNA]] that is [[complementarity (molecular biology)|complementary]] to a [[messenger RNA]] (mRNA) strand [[transcription (genetics)|transcribed]] within a [[cell (biology)|cell]]. Some authors have used the term micRNA (mRNA-interfering complementary RNA) to refer to these RNAs but it is not widely used.<ref name="pmid6201848">{{Cite pmid|6201848}}</ref>


Antisense RNA may be introduced into a cell to inhibit [[translation (genetics)|translation]] of a complementary mRNA by [[base pair]]ing to it and physically obstructing the translation machinery.<ref> Weiss, B., Davidkova, G., and Zhou, L-W.: Antisense RNA gene therapy for studying and modulating biological processes. Cell. Mol. Life Sci. , 55:334-358, 1999.[http://www.ncbi.nlm.nih.gov/pubmed/?term=Weiss%2C+B.%2C+Davidkova%2C+G.%2C+and+Zhou%2C+L-W.%3A+Antisense+RNA+gene+therapy+for+studying+and+modulating+biological+processes.+Cell.+Mol.+Life+Sci.+%2C+55%3A334-358%2C+1999. PubMed]</ref> <ref> Weiss, B. (ed.): Antisense Oligodeoxynucleotides and Antisense RNA : Novel Pharmacological and Therapeutic Agents, CRC Press, Boca Raton, FL, 1997 http://www.amazon.com/Antisense-Oligodeoxynucleotides-RNANovel-Pharmacological-Therapeutic/dp/0849385520/ref=sr_1_4?ie=UTF8&qid=1398175791&sr=8-4&keywords=crc+press+antisense </ref> This effect is therefore [[stoichiometry|stoichiometric]]. An example of naturally occurring mRNA antisense mechanism is the [[hok/sok system]] of the ''[[Escherichia coli|E. coli]]'' R1 plasmid. Antisense RNA has long been thought of as a promising technique for disease therapy; the only such case to have reached the market is the drug [[fomivirsen]]. One commentator has characterized antisense RNA as one of "dozens of technologies that are gorgeous in concept, but exasperating in <nowiki>[commercialization]</nowiki>".<ref name=DePalma2005>{{Cite news
Antisense RNA may be introduced into a cell to inhibit [[translation (genetics)|translation]] of a complementary mRNA by [[base pair]]ing to it and physically obstructing the translation machinery.<ref> Weiss, B., Davidkova, G., and Zhou, L-W.: Antisense RNA gene therapy for studying and modulating biological processes. Cell. Mol. Life Sci. , 55:334-358, 1999.[http://www.ncbi.nlm.nih.gov/pubmed/?term=Weiss%2C+B.%2C+Davidkova%2C+G.%2C+and+Zhou%2C+L-W.%3A+Antisense+RNA+gene+therapy+for+studying+and+modulating+biological+processes.+Cell.+Mol.+Life+Sci.+%2C+55%3A334-358%2C+1999. PubMed]</ref> <ref> Weiss, B. (ed.): Antisense Oligodeoxynucleotides and Antisense RNA : Novel Pharmacological and Therapeutic Agents, CRC Press, Boca Raton, FL, 1997 http://www.amazon.com/Antisense-Oligodeoxynucleotides-RNANovel-Pharmacological-Therapeutic/dp/0849385520/ref=sr_1_4?ie=UTF8&qid=1398175791&sr=8-4&keywords=crc+press+antisense </ref> This effect is therefore [[stoichiometry|stoichiometric]]. An example of naturally occurring mRNA antisense mechanism is the [[hok/sok system]] of the ''[[Escherichia coli|E. coli]]'' R1 plasmid. Antisense RNA has long been thought of as a promising technique for disease therapy; the only such case to have reached the market is the drug [[fomivirsen]]. One commentator has characterized antisense RNA as one of "dozens of technologies that are gorgeous in concept, but exasperating in <nowiki>[commercialization]</nowiki>".<ref name=DePalma2005>{{Cite news

Revision as of 07:45, 11 November 2014

Antisense RNA (asRNA) is a single-stranded RNA that is complementary to a messenger RNA (mRNA) strand transcribed within a cell. Some authors have used the term micRNA (mRNA-interfering complementary RNA) to refer to these RNAs but it is not widely used.[1]

Antisense RNA may be introduced into a cell to inhibit translation of a complementary mRNA by base pairing to it and physically obstructing the translation machinery.[2] [3] This effect is therefore stoichiometric. An example of naturally occurring mRNA antisense mechanism is the hok/sok system of the E. coli R1 plasmid. Antisense RNA has long been thought of as a promising technique for disease therapy; the only such case to have reached the market is the drug fomivirsen. One commentator has characterized antisense RNA as one of "dozens of technologies that are gorgeous in concept, but exasperating in [commercialization]".[4] Generally, antisense RNA still lack effective design, biological activity, and efficient route of administration.[5]

Historically, the effects of antisense RNA have often been confused with the effects of RNA interference (RNAi), a related process in which double-stranded RNA fragments called small interfering RNAs trigger catalytically mediated gene silencing, most typically by targeting the RNA-induced silencing complex (RISC) to bind to and degrade the mRNA. Attempts to genetically engineer transgenic plants to express antisense RNA instead activate the RNAi pathway, although the processes result in differing magnitudes of the same downstream effect; gene silencing. Well-known examples include the Flavr Savr tomato and two cultivars of ringspot-resistant papaya.[6][7]

Transcription of longer cis-antisense transcripts is a common phenomenon in the mammalian transcriptome.[8] Although the function of some cases have been described, such as the Zeb2/Sip1 antisense RNA, no general function has been elucidated. In the case of Zeb2/Sip1,[9] the antisense noncoding RNA is opposite the 5' splice site of an intron in the 5'UTR of the Zeb2 mRNA. Expression of the antisense ncRNA prevents splicing of an intron that contains a ribosome entry site necessary for efficient expression of the Zeb2 protein. Transcription of long antisense ncRNAs is often concordant with the associated protein-coding gene,[10] but more detailed studies have revealed that the relative expression patterns of the mRNA and antisense ncRNA are complex.[11][12]

See also

References

  1. ^ Attention: This template ({{cite pmid}}) is deprecated. To cite the publication identified by PMID 6201848, please use {{cite journal}} with |pmid=6201848 instead.
  2. ^ Weiss, B., Davidkova, G., and Zhou, L-W.: Antisense RNA gene therapy for studying and modulating biological processes. Cell. Mol. Life Sci. , 55:334-358, 1999.PubMed
  3. ^ Weiss, B. (ed.): Antisense Oligodeoxynucleotides and Antisense RNA : Novel Pharmacological and Therapeutic Agents, CRC Press, Boca Raton, FL, 1997 http://www.amazon.com/Antisense-Oligodeoxynucleotides-RNANovel-Pharmacological-Therapeutic/dp/0849385520/ref=sr_1_4?ie=UTF8&qid=1398175791&sr=8-4&keywords=crc+press+antisense
  4. ^ DePalma, Angelo (August 2005). "Twenty-Five Years of Biotech Trends". Genetic Engineering News. Vol. 25, no. 14. Mary Ann Liebert. pp. 1, 14–23. ISSN 1935-472X. Retrieved 2008-08-17.
  5. ^ Antisense Oligonucleotides: Basic Concepts and Mechanisms Nathalie Dias and C. A. Stein. Columbia University, New York, New York 10032
  6. ^ Sanders RA, Hiatt W (2005). "Tomato transgene structure and silencing". Nat Biotechnol. 23 (3): 287–9. doi:10.1038/nbt0305-287b. PMID 15765076.
  7. ^ Chiang CH, Wang JJ, Jan FJ, Yeh SD, Gonsalves D (November 2001). "Comparative reactions of recombinant papaya ringspot viruses with chimeric coat protein (CP) genes and wild-type viruses on CP-transgenic papaya". J. Gen. Virol. 82 (Pt 11): 2827–36. PMID 11602796.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  8. ^ Katayama S, Tomaru Y, Kasukawa T; et al. (September 2005). "Antisense transcription in the mammalian transcriptome". Science. 309 (5740): 1564–6. doi:10.1126/science.1112009. PMID 16141073. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  9. ^ Beltran M, Puig I, Peña C; et al. (March 2008). "A natural antisense transcript regulates Zeb2/Sip1 gene expression during Snail1-induced epithelial-mesenchymal transition". Genes & Development. 22 (6): 756–69. doi:10.1101/gad.455708. PMC 2275429. PMID 18347095. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  10. ^ Engström PG, Suzuki H, Ninomiya N; et al. (April 2006). "Complex Loci in human and mouse genomes". PLoS genetics. 2 (4): e47. doi:10.1371/journal.pgen.0020047. PMC 1449890. PMID 16683030. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link) CS1 maint: unflagged free DOI (link)
  11. ^ Dinger ME, Amaral PP, Mercer TR; et al. (September 2008). "Long noncoding RNAs in mouse embryonic stem cell pluripotency and differentiation". Genome Research. 18 (9): 1433–45. doi:10.1101/gr.078378.108. PMC 2527704. PMID 18562676. {{cite journal}}: Explicit use of et al. in: |author= (help)CS1 maint: multiple names: authors list (link)
  12. ^ Mercer TR, Dinger ME, Sunkin SM, Mehler MF, Mattick JS (January 2008). "Specific expression of long noncoding RNAs in the mouse brain". Proceedings of the National Academy of Sciences of the United States of America. 105 (2): 716–21. doi:10.1073/pnas.0706729105. PMC 2206602. PMID 18184812.{{cite journal}}: CS1 maint: multiple names: authors list (link)
Retrieved from "https://en.wikipedia.org/enwiki/w/index.php?title=Antisense_RNA&oldid=633351299"